Author = Abbas Hajifathali
Adverse Effects of Busulfan Plus Cyclophosphamide versus Busulfan Plus Fludarabine as Conditioning Regimens for Allogeneic Bone Marrow Transplantation

Volume 22, Issue 5, May 2021, Pages 1639-1644

Mahshid Mehdizadeh; Sayeh Parkhideh; Sina Salari; Abbas Hajifathali; Hamid Rezvani; Maryam Mabani


Analyzing Survival Rate of Leukemia Patients Applying Long Term Exponential Model

Volume 21, Issue 6, June 2020, Pages 1539-1543

Mostafa Faridizadeh; Hamid Alavi Majd; Sayeh Parkhideh; Abbas Hajifathali; Mehdi Raei; Nazanin Ramezani; Anahita Saeedi; Ahmad Reza Baghestani


Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma

Volume 20, Issue 12, December 2019, Pages 3797-3803

Faezeh Hosseinzadeh; Jafar Ai; Somayeh Ebrahimi-Barough; Iman Seyhoun; Abbas Hajifathali; Samad Muhammadnejad; Fatemeh Hosseinzadeh; Mahdi Shadnoush; Farnaz Dabiri Oskouei; Javad Verdi


Fas-Antisense Long Noncoding RNA and Acute Myeloid Leukemia: Is There any Relation?

Volume 19, Issue 1, January 2018, Pages 45-48

Arezou Sayad; Abbas Hajifathali; Amir Ali Hamidieh; Farbod Esfandi; Mohammad Taheri


HOTAIR Long Noncoding RNA is not a Biomarker for Acute Myeloid Leukemia (AML) in Iranian Patients

Volume 18, Issue 6, June 2017, Pages 1581-1584

Arezou Sayad; Abbas Hajifathali; Amir Ali Hamidieh; Elham Roshandel; Mohammad Taheri